Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Genomic prognostics in PC salvage radiation

Felix Feng, MD, University of California San Francisco, San Francisco, CA, discusses the validation of a prognostic genomic classifier for salvage radiotherapy prostate cancer (PC) patients from the RTOG 9601 trial who had PSA recurrences after prostatectomy. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.